GlaxoSmithKline and Pfizer, two of the worlds leading developers of AIDS drugs, are pooling their resources by creating a specialist HIV company focused on the disease. FULL STORY
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.